Prior to that, Mike was the GM of Agfa Healthcare’s Cardiology business. During this time, he also served as President of Heartlab, an Agfa acquisition, and led its expansion across Agfa’s global footprint.
Mike earned a BSc in Mechanical Engineering from Notre Dame.
As President, Chief Executive Officer, and a Director of OneMedNet Corporation, Chris willfully leverages this unique background in developing a strong customer-centric organization and culture. At the same time, he is a technology strategist at his core, and continually drives OneMedNet to deliver industry leading solutions as a mechanism to grow market share and identity.
Chris holds BSc and MSc degrees in medicinal chemistry and a PhD in pharmacology from the University of Guelph – Ontario, Canada.
Dr. Yu’s early research and development led to the BEAM solution which helped improve care and outcomes for stroke and trauma patients. In 2009, he started OneMedNet Corporation to commercialize the BEAM product. Since that time, Dr. Yu has remained an integral part of the strategic decision-making within OneMedNet.
Dr. Yu received his BS at U.C. Berkeley, MD at Wake Forest University, and completed his radiology residency and nuclear medicine fellowship at the Mallinckrodt Institute at Washington University.
Having worked in both software design (w/Siemens Healthcare) and clinical applications (w/GE Healthcare), Brian brings a strong user appreciation to product development. More recently, Brian held the position of Director of Clinical Applications for Vital Images (Toshiba Medical Systems) where he honed his leadership skills and clinical imaging proficiency in medical imaging, 3D image processing and imaging informatics. Brian brings OneMedNet a comprehensive background in DICOM data work flow, display and management.
Brian received BSc, MSc and PhD degrees in engineering mechanics and biomedical engineering from the Iowa State University.
His executive experience started with a GM role for GE Healthcare’s Patient Monitoring Division, and was followed by a CEO position for Appleton Cardiology Associates, Ltd. Del then decided to focus his energies on commercializing impactful new medical technologies held by early stage companies. He led the marketing efforts as VP for both TomoTherapy, Inc. and Teramedica, Inc. TomoTherapy enjoyed the largest healthcare IPO of 2007, and TeraMedica was purchased by Fuji Medical in 2015.
Del has a B.S. in Biomedical Engineering from Duke University and an M.B.A. from the University of Michigan.